BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16687401)

  • 1. Allosteric activation of coagulation factor VIIa visualized by hydrogen exchange.
    Rand KD; Jørgensen TJ; Olsen OH; Persson E; Jensen ON; Stennicke HR; Andersen MD
    J Biol Chem; 2006 Aug; 281(32):23018-24. PubMed ID: 16687401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The origins of enhanced activity in factor VIIa analogs and the interplay between key allosteric sites revealed by hydrogen exchange mass spectrometry.
    Rand KD; Andersen MD; Olsen OH; Jørgensen TJ; Ostergaard H; Jensen ON; Stennicke HR; Persson E
    J Biol Chem; 2008 May; 283(19):13378-87. PubMed ID: 18343822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Basis of Enhanced Activity in Factor VIIa-Trypsin Variants Conveys Insights into Tissue Factor-mediated Allosteric Regulation of Factor VIIa Activity.
    Sorensen AB; Madsen JJ; Svensson LA; Pedersen AA; Østergaard H; Overgaard MT; Olsen OH; Gandhi PS
    J Biol Chem; 2016 Feb; 291(9):4671-83. PubMed ID: 26694616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sites involved in intra- and interdomain allostery associated with the activation of factor VIIa pinpointed by hydrogen-deuterium exchange and electron transfer dissociation mass spectrometry.
    Song H; Olsen OH; Persson E; Rand KD
    J Biol Chem; 2014 Dec; 289(51):35388-96. PubMed ID: 25344622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allostery in Coagulation Factor VIIa Revealed by Ensemble Refinement of Crystallographic Structures.
    Sorensen AB; Madsen JJ; Frimurer TM; Overgaard MT; Gandhi PS; Persson E; Olsen OH
    Biophys J; 2019 May; 116(10):1823-1835. PubMed ID: 31003762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of beta strand movement into a zymogen-like position does not confer higher activity to coagulation factor VIIa.
    Olsen OH; Nielsen PF; Persson E
    Biochemistry; 2004 Nov; 43(44):14096-103. PubMed ID: 15518559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factor VII mutant V154G models a zymogen-like form of factor VIIa.
    Toso R; Bernardi F; Tidd T; Pinotti M; Camire RM; Marchetti G; High KA; Pollak ES
    Biochem J; 2003 Feb; 369(Pt 3):563-71. PubMed ID: 12358603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of Zn2+ to a Ca2+ loop allosterically attenuates the activity of factor VIIa and reduces its affinity for tissue factor.
    Petersen LC; Olsen OH; Nielsen LS; Freskgård PO; Persson E
    Protein Sci; 2000 May; 9(5):859-66. PubMed ID: 10850795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric activation of coagulation factor VIIa.
    Persson E; Olsen OH
    Front Biosci (Landmark Ed); 2011 Jun; 16(8):3156-63. PubMed ID: 21622226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beating tissue factor at its own game: Design and properties of a soluble tissue factor-independent coagulation factor VIIa.
    Sorensen AB; Tuneew I; Svensson LA; Persson E; Østergaard H; Overgaard MT; Olsen OH; Gandhi PS
    J Biol Chem; 2020 Jan; 295(2):517-528. PubMed ID: 31801825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel exosite on coagulation factor VIIa and its molecular interactions with a new class of peptide inhibitors.
    Roberge M; Santell L; Dennis MS; Eigenbrot C; Dwyer MA; Lazarus RA
    Biochemistry; 2001 Aug; 40(32):9522-31. PubMed ID: 11583151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational Plasticity-Rigidity Axis of the Coagulation Factor VII Zymogen Elucidated by Atomistic Simulations of the N-Terminally Truncated Factor VIIa Protease Domain.
    Madsen JJ; Olsen OH
    Biomolecules; 2021 Apr; 11(4):. PubMed ID: 33917935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural modulation of factor VIIa by full-length tissue factor (TF
    Prasad R; Sen P
    J Biomol Struct Dyn; 2018 Feb; 36(3):621-633. PubMed ID: 28150568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The factor VII zymogen structure reveals reregistration of beta strands during activation.
    Eigenbrot C; Kirchhofer D; Dennis MS; Santell L; Lazarus RA; Stamos J; Ultsch MH
    Structure; 2001 Jul; 9(7):627-36. PubMed ID: 11470437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of zymogen and activated factor X as scaffolds for the inhibition of the blood coagulation factor VIIa-tissue factor complex by recombinant nematode anticoagulant protein c2.
    Bergum PW; Cruikshank A; Maki SL; Kelly CR; Ruf W; Vlasuk GP
    J Biol Chem; 2001 Mar; 276(13):10063-71. PubMed ID: 11139576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macromolecular substrate affinity for free factor VIIa is independent of a buried protease domain N-terminus.
    Persson E
    Biochem Biophys Res Commun; 2006 Mar; 341(1):28-32. PubMed ID: 16406236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation loop 3 and the 170 loop interact in the active conformation of coagulation factor VIIa.
    Persson E; Olsen OH
    FEBS J; 2009 Jun; 276(11):3099-109. PubMed ID: 19490111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolutionary conservation of the allosteric activation of factor VIIa by tissue factor in lamprey.
    Beeler DL; Aird WC; Grant MA
    J Thromb Haemost; 2018 Apr; 16(4):734-748. PubMed ID: 29418058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
    Norledge BV; Petrovan RJ; Ruf W; Olson AJ
    Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular determinants involved in differential behaviour between soluble tissue factor and full-length tissue factor towards factor VIIa.
    Prasad R; Sen P
    Phys Chem Chem Phys; 2017 Aug; 19(33):22230-22242. PubMed ID: 28799584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.